Intensive glycaemic control and cognitive decline in patients with type 2 diabetes: A meta-analysis

Endocrine Connections

Volumn 4, Issue 2, 2015, Pages R16-R24

  Tuligenga, Richard H ^a,b  

^a HÔPITAL PAUL BROUSSE   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Cognitive decline; Intensive glycaemic control; Meta analysis; Randomised controlled trial; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

COGNITION; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84938973780     PISSN: None     EISSN: 20493614     Source Type: Journal    
DOI: 10.1530/EC-15-0004     Document Type: Review

References (52)

1. Cukierman T, Gerstein HC & Williamson JD. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005 48 2460-2469. (doi:10.1007/ s00125-005-0023-4)
2. Ryan CM & Geckle MO. Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care 2000 23 1486-1493. (doi:10.2337/diacare.23.10.1486)
3. Kanaya AM, Barrett-Connor E, Gildengorin G & Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of theRancho Bernardo study cohort. Archives of Internal Medicine 2004 164 1327-1333. (doi:10.1001/archinte.164.12.1327)
4. Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care 2009 32 221-226. (doi:10.2337/ dc08-1153) (doi:10.2337/dc08-1153)
5. Maggi S, Limongi F, Noale M, Romanato G, Tonin P, Rozzini R, Scafato E, Crepaldi G & ILSA Study Group. Diabetes as a risk factor for cognitive decline in older patients. Dementia and Geriatric Cognitive Disorders 2009 27 24-33. (doi:10.1159/000183842)
6. Tuligenga RH, Dugravot A, Tabák AG, Elbaz A, Brunner EJ, Kivimäki M & Singh-Manoux A. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet. Diabetes & Endocrinology 2014 2 228-235. (doi:10.1016/S2213-8587(13)70192-X)
7. Geijselaers SL, Sep SJ, Stehouwer CD & Biessels GJ. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review. Lancet. Diabetes & Endocrinology 2014 3 75-89. (doi:10.1016/S2213-8587(14)70148-2)
8. Gradman TJ, Laws A, Thompson LW & Reaven GM. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. Journal of the American Geriatrics Society 1993 41 1305-1312.
9. Meneilly GS, Cheung E, Tessier D, Yakura C & Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. Journal of Gerontology 1993 48 M117-M121. (doi:10.1093/geronj/48.4.M117)
10. Naor M, Steingrüber HJ, Westhoff K, Schottenfeld-Naor Y & Gries AF. Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control. Journal of Diabetes and its Complications 1997 11 40-46. (doi:10.1016/1056-8727(95)00106-9)
11. Ryan CM, Freed MI, Rood JA, Cobitz AR, Waterhouse BR & Strachan MW. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006 29 345-351. (doi:10.2337/diacare.29REF6=10.1016/S2213-8587(13)70192-X)
12. Areosa SA & Grimley EV. Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database of Systematic Reviews 2002 4 1-22. CD003804. (doi:10.1002/14651858.CD003804)
13. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine 2008 358 2560-2572. (doi:10.1056/NEJMoa0802987)
14. Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, Sullivan M, Horowitz KR, Ding J, Marcovina S et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet. Neurology 2011 10 969-977. (doi:10.1016/S1474-4422(11)70188-0)
15. Koekkoek PS, Ruis C, van den Donk M, Biessels GJ, Gorter KJ, Kappelle LJ & Rutten GE. Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes-the ADDITION-Netherlands study: a cluster-randomized trial. Journal of the Neurological Sciences 2012 314 71-77. (doi:10.1016/j.jns.2011.10.028)
16. Cukierman-Yaffe T, Bosch J, Diaz R, Dyal L, Hancu N, Hildebrandt P, Lanas F, Lewis BS, MarreM, Yale JF et al. Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial. Lancet. Diabetes & Endocrinology 2014 2 562-572. (doi:10.1016/ S2213-8587(14)70062-2)
17. Chatterjee S, Sharma A, Lichstein E & Mukherjee D. Intensive glucose control in diabetics with an acute myocardial infarction does not improve mortality and increases risk of hypoglycemia-a metaregression analysis. Current Vascular Pharmacology 2013 11 100-104. (doi:10.2174/157016113804547548)
18. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP & Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. Journal of the American Medical Association 2009 301 1565-1572. (doi:10.1001/jama.2009.460)
19. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocrine Practice 2006 12 (Suppl 3) 4-13. (doi:10.4158/EP.12.4.458)
20. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C & Wetterslev J. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2013 11 CD008143. (doi:10.1002/ 14651858.CD008143.pub3)
21. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 352 837-853. (doi:10.1016/S0140-6736(98)07019-6)
22. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998 352 854-865. (doi:10.1016/S0140-6736(98)07037-8)
23. HolmanRR,Paul SK,BethelMA,MatthewsDR&NeilHAW.10-year followup of intensive glucose control in type 2 diabetes. New England Journal of Medicine 2008 359 1577-1589. (doi:10.1056/NEJMoa0806470)
24. Reaven PD,Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R, Emanuele N, Kayshap M, Marks J, Mudaliar S et al. Intensive glucoselowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes 2009 58 2642-2648. (doi:10.2337/db09-0618)
25. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F et al. Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine 2008 358 2545-2559. (doi:10.1056/NEJMoa0802743)
26. Control Group, Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009 52 2288-2298. (doi:10.1007/s00125-009-1470-0)
27. Kawamura T, Umemura T & Hotta N. Cognitive impairment in diabetic patients: can diabetic control prevent cognitive decline? Journal of Diabetes Investigation 2012 3 413-423. (doi:10.1111/j.2040-1124.2012.00234.x)
28. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). UK Prospective Diabetes Study Group. Diabetes Care 1999 22 1125-1136. (doi:10.2337/diacare.22.7.1125)
29. Luchsinger JA, Palmas W, Teresi JA, Silver S, Kong J, Eimicke JP, Weinstock RS & Shea S. Improved diabetes control in the elderly delays global cognitive decline. Journal of Nutrition, Health & Aging 2011 15 445-449. (doi:10.1007/s12603-011-0057-x)
30. Biessels GJ, Deary IJ & Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet. Neurology 2008 7 184-190. (doi:10.1016/S1474-4422(08)70021-8)
31. Velayudhan L, Poppe M, Archer N, Proitsi P, Brown RG & Lovestone S. Risk of developing dementia in people with diabetes andmild cognitive impairment. British Journal of Psychiatry 2010 196 36-40. (doi:10.1192/ bjp.bp.109.067942)
32. Cheng C, Lin CH, Tsai YW, Tsai CJ, Chou PH & Lan TH. Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2014 69 1299-1305. (doi:10.1093/gerona/glu073)
33. Amieva H, Le Goff M, Millet X, Orgogozo JM, Pérès K, Barberger-Gateau P, Jacqmin-Gadda H & Dartigues JF. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Annals of Neurology 2008 64 492-498. (doi:10.1002/ana.21509)
34. Brayne C. The elephant in the room-healthy brains in later life, epidemiology and public health. Nature Reviews. Neuroscience 2007 8 233-239. (doi:10.1038/nrn2091)
35. Hachinski V. Shifts in thinking about dementia. Journal of the American Medical Association 2008 300 2172-2173. (doi:10.1001/jama.2008.525)
36. Moher D, Liberati A, Tetzlaff J, Altman DG & PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. International Journal of Surgery 2010 8 336-341. (doi:10.1016/ j.ijsu.2010.02.007)
37. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011 343 d5928. (doi:10.1136/bmj.d5928)
38. Deeks JJ, Higgins JPT, Altman DG. Analysing and presenting results. In: Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 (updated September 2006) Eds JP Higgins, S Green. Section 8. In The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons Ltd, 2006.
39. Higgins JP, Thompson SG, Deeks JJ & Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 327 557-560. (doi:10.1136/ bmj.327.7414.557)
40. Matthews G, Coyle K & Craig A. Multiple factors of cognitive failure and their relationship with stress vulnerability. Journal of Psychopathology and Behavioral Assessment 1990 12 49-65. (doi:10.1007/ BF00960453)
41. Wagle AC, Berrios GE & Ho L. The cognitive failures questionnaire in psychiatry. Comprehensive Psychiatry 1999 40 478-484. doi:10.1016/ S0010-440X(9REF41=10.1016/S0010-440X(99)90093-7)
42. Gurland B, Kuriansky J, Sharpe L, Simon R, Stiller P & Birkett P. The comprehensive assessment and referral evaluation (CARE)-rationale, development and reliability. International Journal of Aging & Human Development 1977 8 9-42. (doi:10.2190/CL3J-0E20-97XX-MV5L)
43. Gurland B, Wilder D, Cross P, Teresi J & Barrett V. Screening scales for dementia: towards reconciliation of conflicting cross-cultural findings. International Journal of Geriatric Psychiatry 1992 7 105-113. (doi:10.1002/gps.930070207)
44. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine 1993 329 977-986. (doi:10. 1056/NEJM199309303291401)
45. Rawlings AM, Richey Sharrett A, Schneider AL, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Annals of Internal Medicine 2014 161 785-793. (doi:10.7326/M14-0737)
46. De Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia 2009 52 2328-2336. (doi:10.1007/ s00125-009-1484-7)
47. Clinical IDF & Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabetic Medicine 2006 23 579-593. (doi:10.1111/j.1464-5491. 2006.01918.x)
48. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007 30 (Suppl 1) S4-S41. (doi:10.2337/dc07-S004)
49. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). European Heart Journal 2007 28 88-136. (doi:10.1093/eurheartj/ehl260)
50. ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Dıáz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. New England Journal of Medicine 2012 367 319-328. (doi:10.1056/ NEJMoa1203858)
51. Aung PP, Strachan MW, Frier BM, Butcher I, Deary IJ & Price JF. Edinburgh Type 2 Diabetes Study investigators, severe hypoglycaemia and late-life cognitive ability in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetic Medicine 2012 29 328-336. (doi:10REF50=10.1056/NEJMoa1203858)
52. Bruce DG, DavisWA, Casey GP, Clarnette RM, Brown SG, Jacobs IG, Almeida OP & Davis TM. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study. Diabetologia 2009 52 1808-1815. (doi:10.1007/s00125-009-1437-1)